4C Medical Technologies

The First Mitral Regurgitation Therapy that Preserves the Native Mitral Valve

Learn more
4C Medical Technologies

Mitral Regurgitation

Mitral regurgitation (MR) is a common heart valve disease affecting nearly 10 percent of Americans aged ≥75 years. MR occurs when the mitral valve leaflets do not close properly and allow blood in the left ventricle to leak back into the left atrium. It is a progressive disease and if left untreated, MR can lead to atrial fibrillation, pulmonary hypertension, heart failure and death.

Learn more

Latest News

4C Medical Advances the State of the Heart
29-Jun-2018

4C Medical Technologies, Inc. (4C Medical), named after the four chambers of the heart, is developing a novel, minimally invasive device for the treatment of mitral regurgitation (MR). MR impacts up to 10 percen..

Read more
CRT 2018 Award
07-Mar-2018

4C Medical's Transcatheter Mitral Valve Technology Receives First Place in Cardiovascular Research Technologies 2018 Competition BROOKLYN PARK, Minn., March 7, 2018 /PRNewswire/ -- 4C Medical Technologies..

Read more
ICI 2017 Award
05-Dec-2017

4C Medical's Novel Transcatheter Mitral Valve Technology Awarded Best Technology Parade Presentation at ICI 2017 BROOKLYN PARK, Minn., Dec. 5, 2017 /PRNewswire/ -- 4C Medical Technologies, Inc. (4C Medical), a d..

Read more